Drugs /

trans sodium crocetinate

Back to Drugs List

Overview

NCI Definition [1]:
The sodium salt of the trans-isomer of the carotenoid crocetin with potential antihypoxic and radiosensitizing activities. Trans sodium crocetinate (TSC) increases the diffusion rate of oxygen in aqueous solutions such as from plasma to body tissue. The agent has been shown to increase available oxygen during hypoxic and ischemic conditions that may occur in hemorrhage, vascular and neurological disorders, and in the tumor microenvionment.

Clinical Trials

View Clinical Trials for trans sodium crocetinate

Trans sodium crocetinate has been investigated in 1 clinical trial, of which 0 are open and 1 is closed. Of the trial investigating trans sodium crocetinate, 1 is phase 3 (0 open).

Glioblastoma is the most common disease being investigated in trans sodium crocetinate clinical trials [2].

Drug Details

NCIT ID [1]:
C82695

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.